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Abstract
C30H52BN6Tl, monoclinic, P21/n (no. 14), a = 9.611(3) Å,
b = 17.586(5) Å, c = 19.710(6) Å, β = 98.374(7)°,
V = 3295.8(17) Å3, Z = 4, Rgt(F ) = 0.0152, wRref(F
2) = 0.0381,
T = 182 K.
CCDC no.: 2027109
The molecular structure is shown in the Figure. Table 1
contains crystallographic data and Table 2 contains the list
of the atoms including atomic coordinates and displace-
ment parameters.
Source of material
A solution of K{HB(3-tBu-5-iPrpz)3} (326.0mg, 0.596mmol)
in dichloromethane (15 mL) was added to a solution of
TlOAc (192.8 mg, 0.732 mmol) in ethanol (35 mL). The
mixture was stirred for 3 h and the solvent then evaporated
under vacuum. The resulting solid was extracted with
dichloromethane (35 mL). The filtrate was evaporated un-
der vacuum, and a white powder was obtained. Colourless
crystals were obtained by slow evaporation from a satu-
rated dichloromethane/ethanol (5:1 v/v) solution at room
temperature. Yield: 52% (219.3 mg, 0.308 mmol).
Anal. Calcd. for C30H52BN6Tl. C, 50.61; H, 7.36; N,
11.80%. Found: C, 50.22; H, 7.20; N, 11.81%.
IR (JASCO FT/IR-6300 spectrophotometer, KBr; cm−1):
2963 (s) ν(C–H), 2867 (m) ν(C–H), 2562 (m) ν(B–H), 1529 (m)
ν(C=N).
1H NMR (Bruker AVANCE III-500 NMR spectrometer,
chemical shifts relative to CDCl3 298 K; ppm): δ 1.10
(doublet, J = 6.5 Hz, CH(CH3)2, 18H), 1.31 (singlet, C(CH3)3,
27H), 3.34 (septet, J = 6.5 Hz, CH(CH3)2, 3H), 5.85 (singlet,
pyrazole-4, 3H).
13C{1H} NMR (as for 1H NMR) δ: 23.5 [CH(CH3)2], 26.4
[C(CH3)3], 32.3 [CH(CH3)2], 32.5 [C(CH3)3], 98.2 (pyrazole-
4C), 155.5 (pyrazole-3C), 161.8 (pyrazol-5C).
Table : Data collection and handling.
Crystal: Colourless prism
Size: . × . × . mm
Wavelength: Mo Kα radiation (. Å)
μ: . mm−
Diffractometer, scan mode: Rigaku XtaLAB P, ω




Criterion for Iobs, N(hkl)gt: Iobs >  σ(Iobs), 
N(param)refined: 
Programs: NUMABS [], CrystalClear [],
SIR [], SHELX [],
WinGX/ORTEP []
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Experimental details
The C-boundH atomswere geometrically placed (C–H=0.95–





R, R′ = H, alkyl and aryl, are very effective, anionic tripod-
type nitrogen-containing ligands and their coordination
chemistry has provided many fascinating examples of
unusual geometries and reactivities [6, 7]. The steric bulk of
these ligands can be readilymodified by the introduction of
an appropriate alkyl and/or aryl substituent at the 3- and
5-positions of the pyrazolyl rings. For example, by using a
less hindered ligand, [HB(3,5-(iPr)2pz)3]
−, binuclear cop-
per(II) complexes such as the μ-η2:η2-peroxido copper(II)
complex, [{Cu[HB(3,5-(iPr)2pz)3]}2(μ-O2)], and the μ-hydrox-
ido copper(II) complex, [{Cu[HB(3,5-(iPr)2pz]}2(μ-OH)2],
were obtained [8]. On the other hand, in the case of the
highly hindered ligand, [HB(3-tBu-5-iPrpz)3]
−, the mono-
nuclear, side-on superoxido copper(II) complex, [Cu(O2)
{HB(3-tBu-5-iPrpz)3}] [9], and the mononuclear hydroxido
copper(II) complex, [Cu(OH){HB(3-tBu-5-iPrpz)3}] [10], are
selectively formed. Even more hindered adamantyl
substituted ligands were prepared in order to ensure
exclusive mononuclear complex formation [11, 12]. Atten-
tion has also been directed to evaluating the influence of
systematic changes in the steric profiles in these ligands in
thallium(I) complexes, especially with “super-hindered” li-
gands [13, 14]. In continuation of these studies, this report
details the synthesis of a thallium(I) complex with a highly
hindered ligand, i.e. [Tl{HB(3-tBu-5-iPrpz}3], (I), along with
spectroscopic characterization and X-ray crystal structure
determination.
The molecular structure of (I) is illustrated in the
figure (50% displacement ellipsoids) and shows the
thallium(I) centre to be tri-coordinated by three nitro-
gen atoms of the {HB(3-tBu-5-iPrpz)3}
− anion. The Tl—
N11 [2.5352(14) Å], Tl—N21 [2.5363(15) Å] and Tl—N31
[2.5307(15) Å] bond lengths are experimentally equiva-
lent. The resulting N3 donor set defines a trigonal-
pyramidal geometry with the N11—Tl—N21 [74.88(5)°],
N11—Tl—N31 [81.87(5)°] and N21—Tl—N31 [74.74(5)°]
angles spanning a range of about 7°. The molecule ap-
proximates 3-fold symmetry when viewed down the
spine and the Tl-bound lone-pair of electrons is pro-
jected to occupy a position along the extension of this
axis.
Table : Fractional atomic coordinates and isotropic or equivalent
isotropic displacement parameters (Å).
Atom x y z Uiso*/Ueq
Tl . () . () . () . ()
N . () . () . () . ()
N . () . () . () . ()
N . () . () . () . ()
N . () . () . () . ()
N . () . () . () . ()
N . () . () . () . ()
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () −. () . () . ()
HA . −. . .*
HB . −. . .*
HC . −. . .*
C . () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C −. () . () . () . ()
HA −. . . .*
HB −. . . .*
HC −. . . .*
C −. () . () . () . ()
HA −. . . .*
HB −. . . .*
HC −. . . .*
C −. () . () . () . ()
HA −. . . .*
HB −. . . .*
HC −. . . .*
C −. () . () . () . ()
C . () . () . () . ()
C −. () . () . () . ()
H −. . . .*
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
HA −. . . .*
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The same substitution pattern in the pyrazolyl ligand
of (I) is found in a related structure but, containing only two
pyrazolyl residues, i.e. [Tl{H2B(3-tBu-5-iPrpz)2}] [15]. Here,
the thallium(I) centre is bi-coordinated by two pyrazolyl‐N
atoms with the Tl—N bond lengths [2.628(11) and
2.664(10) Å] being longer than those in (I), an observation
explained in terms of the presence of an intramolecular
Tl…HB interaction as well as two close, intermolecular
Tl(lone-pair)…π(pyrazolyl) contacts; see ref. [16] for a
discussion of related intermolecular Tl…π(arene) in-
teractions. In another structure related to (I) where the
t-butyl groups are replaced with adamantanyl sub-
stituents, i.e. [Tl{H2B(3-Ad-5-iPrpz)2}] [14], a disparity ari-
ses in the Tl—Nbond lengths with one bond, i.e. 2.498(3) Å,
being significantly shorter than the other two Tl—N bonds,
i.e. 2.530(4) and 2.538(3) Å. The N—Tl—N angles span a
narrower range in the literature structure, i.e. 74.4(1) to
78.2(1)°, compared with (I). From the foregoing, it is
apparent that no systematic variations in geometric pa-
rameters are evident that can be related to the presence of
t-butyl or adamantanyl substituents in the 3-position of the
pyrazolyl groups in these thallium(I) structures.
In the molecular packing, following the distance criteria
assumed in PLATON [17], there are no directional interactions
between complexes of (I). Thus, an analysis of the calculated
Hirshfeld surfaces and of the full and delineated two-
dimensional fingerprint plots was conducted using Crystal
Explorer 17 [18] and literaturemethods [19].Reflecting the lack
of directional interactions in the crystal, H…H contacts ac-
count for 88.4% of all contacts. The only other contributions
to the calculated Hirshfeld surface are from H…C/C…H
[5.9%], H…N/N…H [4.8%] and H…Tl/Tl…H [0.9%].
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Table : (continued)
Atom x y z Uiso*/Ueq
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
C . () . () . () . ()
H . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
C . () . () . () . ()
HA . . . .*
HB . . . .*
HC . . . .*
B . () . () . () . ()
H . . . .*
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